Impact of Intraprostatic Simultaneous Integrated Boost on Long‐Term Outcomes in Unfavorable Intermediate‐Risk Prostate Cancer Treated With Dose‐Escalated Radiotherapy and Short‐Term Androgen Deprivation Therapy

Documenti analoghi

• Propensity Score Matched Analysis of External Beam Radiotherapy With or Without Focal Boost to Intraprostatic Lesions in Prostate Cancer
  di: Cem Onal, et al.
  Pubblicazione: (2025)
• Nomograms for detecting lymph node metastasis detected with surgery—Can you name any birds other than crow?
  di: Cem Onal, et al.
  Pubblicazione: (2024)
• Evaluating the Prognostic Impact of Apparent Diffusion Coefficient in Definitive Radiotherapy for Gleason Score 7 Prostate Cancer Patients
  di: Cem Onal, et al.
  Pubblicazione: (2024)
• The effect of dose‐escalation radiotherapy with simultaneous‐integrated‐boost on the use of short‐term androgen deprivation therapy in patients with intermediate risk prostate cancer
  di: Cem Onal, et al.
  Pubblicazione: (2024)
• Impact of definitive radiotherapy on metabolic response measured with 68Ga‐PSMA‐PET/CT in patients with intermediate‐risk prostate cancer
  di: Cem Onal, et al.
  Pubblicazione: (2024)